Cheap Antidepressant Shows Promise Treating Early COVID-19
Researchers found an affordable antidepressant can treat COVID-19 in the early stages.
A cheap antidepressant reduced the need for hospitalization among high-risk adults with COVID-19 in a study hunting for existing drugs that could be repurposed to treat coronavirus.
Researchers tested the pill used for depression and obsessive-compulsive disorder because it was known to reduce inflammation and looked promising in smaller studies.
They've shared the results with the U.S. National Institutes of Health, which publishes treatment guidelines, and they hope for a World Health Organization recommendation.
"If WHO recommends this, you will see it widely taken up," said study co-author Dr. Edward Mills of McMaster University in Hamilton, Ontario, adding that many poor nations have the drug readily available. "We hope it will lead to a lot of lives saved."
The pill, called fluvoxamine, would cost $4 for a course of COVID-19 treatment. By comparison, antibody IV treatments cost about $2,000 and Merck's experimental antiviral pill for COVID-19 is about $700 per course. Some experts predict various treatments eventually will be used in combination to fight the coronavirus.
Researchers tested the antidepressant in nearly 1,500 Brazilians recently infected with coronavirus who were at risk of severe illness because of other health problems, such as diabetes. About half took the antidepressant at home for 10 days, the rest got dummy pills. They were tracked for four weeks to see who landed in the hospital or spent extended time in an emergency room when hospitals were full.
In the group that took the drug, 11% needed hospitalization or an extended ER stay, compared to 16% of those on dummy pills.
The results, published Wednesday in the journal Lancet Global Health, were so strong that independent experts monitoring the study recommended stopping it early because the results were clear.
Questions remain about the best dosing, whether lower risk patients might also benefit and whether the pill should be combined with other treatments.
The larger project looked at eight existing drugs to see if they could work against the pandemic virus. The project is still testing a hepatitis drug, but all the others — including metformin, hydroxychloroquine and ivermectin — haven't panned out.
The cheap generic and Merck's COVID-19 pill work in different ways and "may be complementary," said Dr. Paul Sax of Brigham and Women's Hospital and Harvard Medical School, who was not involved in the study. Earlier this month, Merck asked regulators in the U.S. and Europe to authorize its antiviral pill.
Additional reporting by The Associated Press.
China Eases Virus Controls Amid Effort To Head Off Protests
In some areas, markets and bus service reopened, and a newspaper reported Beijing has begun allowing some people with the virus to isolate at home.By AP Photo
Seniors Are Experiencing Record-High RSV Cases
The latest CDC data from November shows this year, the rate of hospitalization for seniors with RSV is already 10 times higher than average.By Steven Senne / AP
China Vows Crackdown On 'Hostile Forces' As Public Tests Xi
The statement from Chinese officials comes amid a massive show of force by security services to deter protests against strict "zero-COVID" lockdowns.By Andy Wong / AP
Georgia, Michigan, TCU, Ohio State Advance To College Football Playoff
Georgia and Ohio State will face off in the Peach Bowl, while Michigan will go up against Texas Christian University in the Fiesta Bowl.By John Bazemore / AP
World Cup Fans Find Booze At Hotels, Qatar's 1 Liquor Store
The only store currently selling liquor in Qatar operates on an appointment system.By Petr Josek / AP
'Sesame Street' Legend Bob McGrath Dies At 90
McGrath was a founding cast member of "Sesame Street" when the show premiered in 1969, playing friendly neighbor Bob Johnson.By Chris Pizzello / AP